Your browser doesn't support javascript.
loading
Doxorubicin Detoxification in Healthy Organs Improves Tolerability to High Drug Doses for Enhanced Antitumor Therapy.
Jiang, Qi; Chen, Mengchun; Yang, Xuewei; Zhuge, Deli; Yin, Qingqing; Tian, Dongyan; Li, Li; Zhang, Xufei; Xu, Wenbin; Liu, Shuangshuang; Li, Fan; Weng, Cuiye; Lin, Yijing; Wang, Haonan; Rao, Dapang; Chen, Yiming; Cai, Qiangjun; Yan, Linzhi; Wang, Ledan; Wang, Fang; Lu, Xiaosheng; Wen, Bin; Zhao, Yingzheng; Zhang, Feng; Xia, Weiliang; Zhu, Haiyan; Chen, Yijie.
Afiliación
  • Jiang Q; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Chen M; International Institutes of Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu 322000, China.
  • Yang X; Department of Pharmacy, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Zhuge D; Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo 315302, China.
  • Yin Q; Department of Pharmaceutics, School of Pharmaceutical Sciences of Wenzhou Medical University, Wenzhou 325035, China.
  • Tian D; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Li L; Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo 315302, China.
  • Zhang X; Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo 315302, China.
  • Xu W; Department of Pharmaceutics, School of Pharmaceutical Sciences of Wenzhou Medical University, Wenzhou 325035, China.
  • Liu S; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Li F; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Weng C; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Lin Y; Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo 315302, China.
  • Wang H; Wenzhou Medical University, Wenzhou 325035, China.
  • Rao D; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Chen Y; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Cai Q; State Key Laboratory of Oncogenes and Related Genes, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China.
  • Yan L; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Wang L; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Wang F; Department of Pharmaceutics, School of Pharmaceutical Sciences of Wenzhou Medical University, Wenzhou 325035, China.
  • Lu X; Wenzhou Medical University, Wenzhou 325035, China.
  • Wen B; Wenzhou Medical University, Wenzhou 325035, China.
  • Zhao Y; Wenzhou Medical University, Wenzhou 325035, China.
  • Zhang F; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Xia W; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Zhu H; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Chen Y; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
ACS Nano ; 17(8): 7705-7720, 2023 04 25.
Article en En | MEDLINE | ID: mdl-37022161
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas / Neoplasias / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: ACS Nano Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas / Neoplasias / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: ACS Nano Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos